✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Concord Biotech Ltd.

CONCORDBIO

Market Cap
₹19,094 Cr.
P/E
51.38

Concord Biotech Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
19,094 Cr
PE
PE
51.38
Prom Holding
Prom Holding
44.08 %
ROE (%)
ROE (%)
20.18
ROCE (%)
ROCE (%)
26.46
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1,200 Cr
OPM (%)
OPM (%)
42.19 %
Debt to Equity
Debt to Equity
0.00
View more
Edit Ratio's
About
Concord Biotech Limited, an India-based biopharmaceutical company, is a major global player in… Read more
Low
1345
52W Range
High
2664
  • Concord Biotech
  • Biocon
  • Guj. Themis Biosyn
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
20 %
(as of Jun 24)
Historic
Fermentation Based API Products - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Europe DMF Filings (.)
      Source
    • Global DMFs filed (.)
      Source
    • Total reactor capacity (kL)
      Source
    • Japan DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Concord Biotech Ltd. Business

    Concord Biotech Limited, an India-based biopharmaceutical company, specializes in fermentation-based APIs for Immunosuppressants and oncology. It has a strong global presence in the US, Europe, and Japan with an expanding formulation business.

    Concord Biotech major competitors are Biocon, Guj. Themis Biosyn, Advanced Enzyme, Fermenta Biotech, Jubilant Pharmova, Alembic Pharma, Caplin Point Lab.
    Market Cap of Concord Biotech is ₹19,094 Crs.
    While the median market cap of its peers are ₹15,845 Crs.

    Concord Biotech seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation May Mar Jun Sep Dec Jun Sep Dec
    Conference Call Mar Mar Jun Sep Dec Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Concord Biotech Ltd.
    View The Discussion On Valuepickr
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material